Aims and Scope

CVIR Endovascular is a new multidisciplinary open access journal in the fast-developing field of endovascular treatment. The journal publishes papers on minimally invasive vascular surgical interventions. Diagnostic papers are only published if there is a relation to endovascular treatment. The multidisciplinary journal is intended for ALL specialists working in the field of endovascular treatment.


CVIR Endovascular publishes manuscripts in the area of venous and arterial interventions, including vascular malformations, non-oncological embolisation, peripheral vascular interventions, aortic interventions, emergency medicine and carotid interventions.



CVIR Endovascular publishes a range of manuscript types including original clinical investigations, systematic reviews, case reports and technical reports. We would like to receive manuscripts in accordance with the international standards for publishing. For more information on these guidelines, visit this page on our site.


The field of endovascular treatment is very dynamic and new ideas need rapid communication so that the latest information is available to treat our patients. CVIR Endovascular also wants to stimulate scientific discussions and provide a podium to discuss your research work with your peers. It is the first open peer review journal in the field of endovascular interventions.


CVIR Endovascular is embedded within the Cardiovascular and Interventional Society of Europe (CIRSE).


Prof. Jim A. Reekers is a professor emeritus of radiology and interventional radiology at the University of Amsterdam. He is well-known in IR circles and has been a driving force in CIRSE, serving as president of the society from 2007 to 2009. A pioneer of subintimal angioplasty, Prof. Reekers has also developed numerous techniques, catheters and filters. But perhaps his most important contribution to IR have been his untiring efforts to establish IR as an evidence-based and clinical trial-driven discipline. Prof. Reekers has authored more than 150 peer-reviewed publications and 22 book chapters. His research interest is critical limb ischemia, especially in diabetic disease and includes both imaging and treatment.

Words from From the Editor-in -Chief, Prof. Jim A. Reekers

HTML5 Icon

Endovascular treatment is a multidisciplinary profession which is producing a constant stream of new technologies and scientific publications. Interventional radiologists, vascular surgeons, cardiologists and angiologists are all active in this field. There are several models of how physicians in these fields work individually or as a team.

The developments in endovascular treatment are presented at an exceptional pace, whether that be through modifications of existing technologies or completely new pathways. Fast communication without borders and hurdles is therefore needed, and open access is the way forward. Currently, the few existing vascular surgery or interventional radiology journals only have limited space for endovascular publications. With this limited space, it is unavoidable that many good papers are rejected. Also, over 90% of case reports and technical notes that are not only interesting, but vital to the work we do, are being rejected.


CVIR Endovascular was created as a platform to publish papers focused on endovascular treatment and to communicate to the endovascular community through a constant stream of publications.

Discussions among peers have been fundamental to the development of endovascular treatment. We would like to keep this tradition alive by opening, together with the journal, a discussion platform for the whole endovascular community. 

CVIR Endovascular seeks to facilitate an environment of engaging with, learning from, and questioning your peers. 

A fast and effective peer review process, in line with the characteristics of the endovascular attitude, will ensure a rapid appraisal of manuscripts. The CVIR Endovascular Editorial Board has been formed thanks to the availability of skilled and enthusiastic experts in endovascular treatment.

The Open Access model of the journal offers a fast and reliable way to disseminate knowledge and can be supported with several funding schemes in case authors are in need of resources for article publication.

Besides original articles, CVIR Endovascular is aimed at publishing case reports, technical notes, reviews and short communications. Comments and ideas can be shared within the scientific community through Editorials and Letters to the Editor.

We are confident CVIR Endovascular will actively contribute to creating a bridge between different modalities that are in charge of endovascular treatment and will facilitate their use in the scientific community. 

Jim A. Reekers